Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02578043Phase 1Completed
Phase 1, randomised, double-blind trial of clindamycin + benzoyl peroxide in acne vulgaris (3 arms). Primary endpoint: Demonstration of Bioequivalence at 12 weeks. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02578043.